Standard Biotools

Yahoo Finance • 3 months ago

Is Standard BioTools Inc. (LAB) the Best NASDAQ Stock Under $5?

We recently compiled a list of 7 Best NASDAQ Stocks Under $5. In this article, we will look at where Standard BioTools Inc. (NASDAQ:LAB) ranks among the best NASDAQ stocks under $5. Job Market Cools Yet Economists Remain Optimistic About... Full story

Yahoo Finance • last year

11 Stocks Under $5 With High Potential

In this article, we will take a look at 11 stocks under $5 with high potential. To skip our analysis of the recent market activity, you can go directly to see the 5 Stocks Under $5 With High Potential. U.S. stocks posted the seventh conse... Full story

Yahoo Finance • last year

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JVA, SMMF, RPT, LAB

NEW YORK, Nov. 18, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • last year

Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results

Year-to-date revenue growth, gross margin expansion and operating expense reduction are testament to continued execution against financial objectivesPlanned merger with SomaLogic activates strategic M&A thesis SOUTH SAN FRANCISCO, Calif.,... Full story

Yahoo Finance • last year

Standard BioTools to Present at the Jefferies London Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that President and Chief Execut... Full story

Yahoo Finance • last year

Standard BioTools Announces Conference Call and Webcast of Third Quarter 2023 Financial Results on November 7, 2023

SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that it will report third quart... Full story

Yahoo Finance • last year

Moore Kuehn Encourages VERY, PNT, LAB, and LVOX Investors to Contact Law Firm

NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mer... Full story

Yahoo Finance • last year

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SP, ORTX, LAB, SLGC

NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • last year

Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools

Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of multi-omic technologies with the highest throughput and highest data quality to power clinical research... Full story

Yahoo Finance • 2 years ago

Standard BioTools to Participate in Upcoming Investor Conferences

Standard BioTools Inc. SOUTH SAN FRANCISCO, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced Company... Full story

Yahoo Finance • 2 years ago

With 45% ownership, Standard BioTools Inc. (NASDAQ:LAB) has piqued the interest of institutional investors

Key Insights Given the large stake in the stock by institutions, Standard BioTools' stock price might be vulnerable to their trading decisions 52% of the business is held by the top 7 shareholders Insiders have been buying lately A look... Full story

Yahoo Finance • 2 years ago

Standard BioTools Announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System

SOUTH SAN FRANCISCO, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced the launch of NGS library prepar... Full story

Yahoo Finance • 2 years ago

Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience Vikram Jog to become Special Advisor for transition period SOUTH SAN FRANCISCO, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Standard BioTools... Full story

Yahoo Finance • 2 years ago

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, granted e... Full story

Yahoo Finance • 2 years ago

Standard BioTools to Present at 43rd Annual Cowen Health Care Conference

SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that President and Chief Execu... Full story

Yahoo Finance • 2 years ago

Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook

Fourth quarter 2022 GAAP revenues of $27.0 million; Core product and service revenues of $26.8 million, representing 8.3% sequential growth; Full year GAAP revenues of $97.9 million and core product and service revenues of $94.5 million I... Full story

Yahoo Finance • 2 years ago

Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results

SOUTH SAN FRANCISCO, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that it will report fourth quar... Full story